Clinical Trial: Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis

U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07008846) titled 'Efficacy of Tofacitinib, Methotrexate Combination Therapy Versus Upadacitinib, Methotrexate Combination Therapy in Moderate to Severe Rheumatoid Arthritis' on May 11.

Brief Summary: The aim of this study is to assess the efficacy of upadacitinib, methotrexate combination therapy in comparison to tofacitinib, methotrexate combination therapy in moderate to severe RA patients. This study will guide us to treat RA patients with inadequate response to methotrexate more effectively

Study Start Date: May 10

Study Type: INTERVENTIONAL

Condition: Moderate to Severe Rheumatoid Arthritis

Intervention: DRUG: To see the efficacy of Upadaci...